SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing ...
Revelation Biosciences (REVB) announced successful submission and acceptance of the end-of-phase 1 meeting package to FDA and that the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback